scispace - formally typeset
L

Lynn A. Fairbanks

Researcher at University of California, Los Angeles

Publications -  177
Citations -  17484

Lynn A. Fairbanks is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Population & Vervet monkey. The author has an hindex of 66, co-authored 176 publications receiving 16869 citations. Previous affiliations of Lynn A. Fairbanks include United States Department of Veterans Affairs & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Life Threat and Posttraumatic Stress in School-age Children

TL;DR: The results provide strong evidence that acute PTSD symptoms occur in school-age children with a notable correlation between proximity to the violence and type and number of PTSD symptoms.
Journal ArticleDOI

Apathy Is Not Depression

TL;DR: This article performed a cross-sectional comparison of neuropsychiatric symptoms in 30 Alzheimer's disease, 28 frontotemporal dementia, 40 Parkinson disease, 34 Huntington disease, and 22 progressive supranuclear palsy patients, using a standardized rating scale (the Neuropsychiatric Inventory).
Journal ArticleDOI

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.

TL;DR: The authors compared 10 nondepressed patients with obsessive-compulsive disorder with 10 normal control subjects of the same sex and similar age for cerebral glucose metabolic rates obtained using positron emission tomography.
Journal ArticleDOI

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

TL;DR: In this paper, the authors examined baseline regional metabolic abnormalities and metabolic changes from pretreatment to post-treatment in subjects with major depressive disorder (MDD) and performed a preliminary comparison of regional changes with two distinct forms of treatment (paroxetine and interpersonal psychotherapy) and found that subjects with MDD had metabolic changes in the direction of normalization in these regions.

Regional Brain Metabolic Changes in Patients With Major Depression Treated With Either Paroxetine or Interpersonal Therapy

TL;DR: Subjects with MDD had regional brain metabolic abnormalities at baseline that tended to normalize with treatment, and regional metabolic changes appeared similar with the 2 forms of treatment.